| Identification | Back Directory | [Name]
Methanone, [8-[(3-fluorophenyl)sulfonyl]-3,8-diazabicyclo[3.2.1]oct-3-yl]-1H-1,2,3-triazol-5-yl- | [CAS]
2160582-57-8 | [Synonyms]
Obafistat
Obafistat,Inhibitor,inhibit
Methanone, [8-[(3-fluorophenyl)sulfonyl]-3,8-diazabicyclo[3.2.1]oct-3-yl]-1H-1,2,3-triazol-5-yl- | [Molecular Formula]
C15H16FN5O3S | [MDL Number]
MFCD34567170 | [MOL File]
2160582-57-8.mol | [Molecular Weight]
365.38 |
| Chemical Properties | Back Directory | [Boiling point ]
623.3±65.0 °C(Predicted) | [density ]
1.533±0.06 g/cm3(Predicted) | [storage temp. ]
4°C, protect from light | [solubility ]
DMSO : 62.5 mg/mL (171.05 mM; ultrasonic and warming and heat to 60°C) | [form ]
Solid | [pka]
7.66±0.70(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
Obafistat is a potent aldo-keto reductase AKR1C3 inhibitor with an IC50 of 1.2 nM for human AKR1C3 (patent WO2017202817A1, example 4)[1]. | [storage]
4°C, protect from light | [References]
[1] Marcus Koppitz, et al. [8-(phenylsulfonyl)-3,8-diazabicyclo[3.2.1]oct-3-yl] (1h-1,2,3-triazol-4-yl)methanones. WO2017202817A1. |
|
|